热门资讯> 正文
Aptose普通股将从纳斯达克退市
2025-04-01 20:46
- Aptose Biosciences (NASDAQ:APTO) announced that Nasdaq has determined to delist the common shares of the company, as of April 2, 2025.
- Under the terms of the Nasdaq’s decision in this matter, the company was required to demonstrate compliance with the Exchange’s equity requirement rule on or before March 31.
- APTO -37.77% premarket to $1.96.
- Source: Press Release
More on Aptose Biosciences
- Aptose Biosciences GAAP EPS of -$36.38
- Aptose Biosciences approves 1-for-30 reverse share split to restore Nasdaq compliance
- Seeking Alpha’s Quant Rating on Aptose Biosciences
- Historical earnings data for Aptose Biosciences
- Financial information for Aptose Biosciences
推荐文章
风险及免责提示：以上内容仅代表作者的个人立场和观点，不代表华盛的任何立场，华盛亦无法证实上述内容的真实性、准确性和原创性。投资者在做出任何投资决定前，应结合自身情况，考虑投资产品的风险。必要时，请咨询专业投资顾问的意见。华盛不提供任何投资建议，对此亦不做任何承诺和保证。
